These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 20104024

  • 1. Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells.
    Huang S, Sinicrope FA.
    Autophagy; 2010 Feb; 6(2):256-69. PubMed ID: 20104024
    [Abstract] [Full Text] [Related]

  • 2. Autophagy blockade sensitizes the anticancer activity of CA-4 via JNK-Bcl-2 pathway.
    Li Y, Luo P, Wang J, Dai J, Yang X, Wu H, Yang B, He Q.
    Toxicol Appl Pharmacol; 2014 Jan 15; 274(2):319-27. PubMed ID: 24321340
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling.
    Koehler BC, Jassowicz A, Scherr AL, Lorenz S, Radhakrishnan P, Kautz N, Elssner C, Weiss J, Jaeger D, Schneider M, Schulze-Bergkamen H.
    BMC Cancer; 2015 Nov 19; 15():919. PubMed ID: 26585594
    [Abstract] [Full Text] [Related]

  • 5. BH3 mimetic ABT-737 potentiates TRAIL-mediated apoptotic signaling by unsequestering Bim and Bak in human pancreatic cancer cells.
    Huang S, Sinicrope FA.
    Cancer Res; 2008 Apr 15; 68(8):2944-51. PubMed ID: 18413764
    [Abstract] [Full Text] [Related]

  • 6. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.
    van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, Czabotar PE, Willis SN, Scott CL, Day CL, Cory S, Adams JM, Roberts AW, Huang DC.
    Cancer Cell; 2006 Nov 15; 10(5):389-99. PubMed ID: 17097561
    [Abstract] [Full Text] [Related]

  • 7. p62/sequestosome-1 up-regulation promotes ABT-263-induced caspase-8 aggregation/activation on the autophagosome.
    Huang S, Okamoto K, Yu C, Sinicrope FA.
    J Biol Chem; 2013 Nov 22; 288(47):33654-33666. PubMed ID: 24121507
    [Abstract] [Full Text] [Related]

  • 8. Decreased sensitivity of 17p-deleted chronic lymphocytic leukemia cells to a small molecule BCL-2 antagonist ABT-737.
    Kojima K, Duvvuri S, Ruvolo V, Samaniego F, Younes A, Andreeff M.
    Cancer; 2012 Feb 15; 118(4):1023-31. PubMed ID: 21761401
    [Abstract] [Full Text] [Related]

  • 9. The pro-survival role of autophagy depends on Bcl-2 under nutrition stress conditions.
    Xu HD, Wu D, Gu JH, Ge JB, Wu JC, Han R, Liang ZQ, Qin ZH.
    PLoS One; 2013 Feb 15; 8(5):e63232. PubMed ID: 23658815
    [Abstract] [Full Text] [Related]

  • 10. [Bcl-2 inhibitor ABT-737 enhances the cisplatin-induced apoptosis in breast cancer T47D cells].
    Chen ZJ, Zhang B, Pan SH, Zhao HM, Zhang Y, Feng WH, Li YY, Cao XC.
    Zhonghua Zhong Liu Za Zhi; 2011 Dec 15; 33(12):891-5. PubMed ID: 22340096
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis.
    Song JH, Kandasamy K, Kraft AS.
    J Biol Chem; 2008 Sep 05; 283(36):25003-13. PubMed ID: 18599488
    [Abstract] [Full Text] [Related]

  • 13. Dual Akt and Bcl-2 inhibition induces cell-type specific modulation of apoptotic and autophagic signaling in castration resistant prostate cancer cell lines.
    Avsar Abdik E, Abdik H, Turan D, Sahin F, Berger MR, Kaleagasioglu F.
    Mol Biol Rep; 2021 Dec 05; 48(12):7755-7765. PubMed ID: 34647221
    [Abstract] [Full Text] [Related]

  • 14. Phosphoinositide 3-kinase/AKT/mTORC1/2 signaling determines sensitivity of Burkitt's lymphoma cells to BH3 mimetics.
    Spender LC, Inman GJ.
    Mol Cancer Res; 2012 Mar 05; 10(3):347-59. PubMed ID: 22241218
    [Abstract] [Full Text] [Related]

  • 15. pRb/E2F-1-mediated caspase-dependent induction of Noxa amplifies the apoptotic effects of the Bcl-2/Bcl-xL inhibitor ABT-737.
    Bertin-Ciftci J, Barré B, Le Pen J, Maillet L, Couriaud C, Juin P, Braun F.
    Cell Death Differ; 2013 May 05; 20(5):755-64. PubMed ID: 23429261
    [Abstract] [Full Text] [Related]

  • 16. BMX acts downstream of PI3K to promote colorectal cancer cell survival and pathway inhibition sensitizes to the BH3 mimetic ABT-737.
    Potter DS, Kelly P, Denneny O, Juvin V, Stephens LR, Dive C, Morrow CJ.
    Neoplasia; 2014 Feb 05; 16(2):147-57. PubMed ID: 24709422
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.
    Konopleva M, Contractor R, Tsao T, Samudio I, Ruvolo PP, Kitada S, Deng X, Zhai D, Shi YX, Sneed T, Verhaegen M, Soengas M, Ruvolo VR, McQueen T, Schober WD, Watt JC, Jiffar T, Ling X, Marini FC, Harris D, Dietrich M, Estrov Z, McCubrey J, May WS, Reed JC, Andreeff M.
    Cancer Cell; 2006 Nov 05; 10(5):375-88. PubMed ID: 17097560
    [Abstract] [Full Text] [Related]

  • 18. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.
    Chen S, Dai Y, Harada H, Dent P, Grant S.
    Cancer Res; 2007 Jan 15; 67(2):782-91. PubMed ID: 17234790
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH, Wan Z, Kang YH, Sposto R, Reynolds CP.
    J Natl Cancer Inst; 2008 Apr 16; 100(8):580-95. PubMed ID: 18398104
    [Abstract] [Full Text] [Related]

  • 20. Pro-survival responses to the dual inhibition of anti-apoptotic Bcl-2 family proteins and mTOR-mediated signaling in hypoxic colorectal carcinoma cells.
    Risberg K, Redalen KR, Sønstevold L, Bjørnetrø T, Sølvernes J, Ree AH.
    BMC Cancer; 2016 Jul 26; 16():531. PubMed ID: 27461218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.